According to a new study, cannabinoids can attenuate (reduce the effects of) hyperactivity and body weight loss in activity-based anorexia.
The study, published by the British Journal of Pharmacology, was epublished ahead of print by the U.S. National Institute of Health.
“Anorexia nervosa (AN) is a serious psychiatric condition characterized by excessive body weight loss and disturbed perceptions of body shape and size, often associated with excessive physical activity”, states the study’s abstract. “There is currently no effective drug-related therapy of this disease and this leads to high relapse rate. Clinical data suggest that a promising therapy to treat and reduce reoccurrence of AN may be based on the use of drugs that target the endocannabinoid (EC) system [such as cannabinoids], which appears dysregulated in AN patients.”